Abstract
Objective. Pseudomonas aeruginosa is a present everywhere and opportunistic bacterium pathogen. The existence of numerous virulence factors i.e. exo-toxin, exo-enzyme genes, and biofi lm may be contributed in the pathogenesis and pathogenicity of the bacterium. The goals of the present work were to detect biofilm formation, some biofilm genes, and the effect of antibiotics against P. aeruginosa. Methods. All isolates were identified using API 20E and 16S rRNA techniques. The microtiter plate method (MTPM) was used to detect biofi lm formation. Th e polymerase chain reaction (PCR) was used to fi nd some virulence genes e.g. pelA, pslA. Results. A total of 64 P. aeruginosa isolates were identified as P. aeruginosa. The majority of infection belonged to burn infections — 27 (42.2%), followed by ear — 17 (26.5%), and urine — 20 (31.3%). The results of biofilm detection using MTPM showed that all P. aeruginosa isolates were able to produce biofilm but at different levels. PCR technique was used to detect biofilm genes. Studies showed that 61 (95.30%) and 63 (99.32%) isolates carried pelA and pslA genes, respectively. Moreover, a susceptibility test was used to select 10 antibiotics. P. aeruginosa isolates were resistant to cefotaxime — 61 (95.3%), carbenicillin — 59 (92.2%), ampicillin — 38 (59.4%), piperacilin/tazobactam — 29 (45.3%), streptomycin — 28 (43.8%), moxifloxacin — 27 (42.4%), ticarcilin — 26 (40.6%), ciprofloxacin — 24 (37.5%), gentamicin — 20 (31.3%), and neomycin — 13 (20.3%). Conclusions. Biofilm is produced by P. aeruginosa at different levels. The molecular technique showed that the pelA and pslA genes are associated with the form of biofilm in P. aeruginosa isolates. The susceptibility tests showed that the most active antibiotics against P. aeruginosa were neomycin, gentamycin, and ciprofloxacin, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.